Cargando…

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all

Detalles Bibliográficos
Autor principal:	Więsik-Szewczyk, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2021
Materias:	Editorial Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768034/ https://www.ncbi.nlm.nih.gov/pubmed/35079177 http://dx.doi.org/10.5114/reum.2021.112348

Ejemplares similares

Monogenic autoinflammatory diseases in adults – a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment
por: Milchert, Marcin, et al.
Publicado: (2019)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
por: Gaggiano, Carla, et al.
Publicado: (2022)

In tuberculosis, “one size does not fit all”
por: Bhargava, Salil, et al.
Publicado: (2019)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

Postoperative bronchopleural fistula: Does one size fit all?
por: Muthu, Valliappan, et al.
Publicado: (2020)

Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
por: Beck, David B., et al.
Publicado: (2019)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
por: Figueras-Nart, Ignasi, et al.
Publicado: (2019)

One Size Does Not Fit All: Achieving Trachoma Control by 2030
por: Oldenburg, Catherine E.
Publicado: (2019)

One size does not fit all: prediction of presence of pleural adhesions
por: Tokuno, Junko, et al.
Publicado: (2023)

Racial Differences in Response to Antihypertensive Therapy: Does One Size Fits All?
por: Gupta, Ajay K
Publicado: (2010)

One size does not fit all
por: Tautz, Diethard
Publicado: (2014)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
por: Di Donato, Giulia, et al.
Publicado: (2021)

One-size MAP does not fit all
por: Senussi, Mourad H
Publicado: (2015)

Commentary: One size does not fit all
por: Jethani, Jitendra
Publicado: (2018)

Rapamycin – “One size does not fit all”
por: Kallijärvi, Jukka, et al.
Publicado: (2019)

Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood
por: Welzel, Tatjana, et al.
Publicado: (2021)

Lung pathophysiology in patients with long COVID-19: one size definitely does not fit all
por: Radovanovic, Dejan, et al.
Publicado: (2023)

One size does not fit all: on the need for categorical stratification in nutrition science, practice and policy
por: Kohlmeier, Martin
Publicado: (2023)

Time to Reject the “One Size Fits All” Myth
Publicado: (2014)

Anticoagulation strategies in continuous kidney replacement therapy — does one size fit all?
por: Deep, Akash
Publicado: (2022)

The classification, genetic diagnosis and modelling of monogenic autoinflammatory disorders
por: Moghaddas, Fiona, et al.
Publicado: (2018)

Travellers' malaria - 'one shoe does not fit all'
por: Schlagenhauf, Patricia, et al.
Publicado: (2011)

Immunosuppression and herpes viral reactivation in intensive care unit patients: one size does not fit all
por: Textoris, Julien, et al.
Publicado: (2017)

One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19
por: Amati, Francesco, et al.
Publicado: (2021)

Bilateral internal mammary arteries for coronary artery bypass grafting: One size does not fit all
por: EL-Andari, Ryaan, et al.
Publicado: (2023)

Tissue microarrays: one size does not fit all
por: Eckel-Passow, Jeanette E, et al.
Publicado: (2010)

Hepatorenal syndrome: one size does not fit all
por: Parikh, Amay, et al.
Publicado: (2012)

Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
por: Hentgen, Véronique, et al.
Publicado: (2021)

Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
por: Pelagatti, Maria A, et al.
Publicado: (2014)

Altered cytokine pattern and inflammatory pathways in monogenic and complex autoinflammatory diseases
por: Galozzi, P, et al.
Publicado: (2015)

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases
por: Gaggiano, Carla, et al.
Publicado: (2019)

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases
por: Galozzi, Paola, et al.
Publicado: (2022)

National Exit Test: How Will One Size Fit All?
por: Ranjan, Piyush, et al.
Publicado: (2020)

Hearing Loss as the Main Clinical Presentation in NLRP3-Associated Autoinflammatory Disease
por: Oziębło, Dominika, et al.
Publicado: (2022)

One size does not fit all: working towards increasing participation of minority groups in cancer screening programmes
Publicado: (2023)

Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders
por: Vitale, Antonio, et al.
Publicado: (2013)

Direct oral anticoagulation and severe obesity – One size fits all?
por: Fender, Anke C., et al.
Publicado: (2021)

Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations
por: Martorana, Davide, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1hd3ps59pise3iu10a9u5sp5ff